Liming Wang
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Surgery 15
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Jianxiong Wu (25 shared papers)Weiqi Rong (21 shared papers)Fan Wu (16 shared papers)Weihu Wang (9 shared papers)Bo Chen (7 shared papers)Weibo Yu (9 shared papers)Liguo Liu (4 shared papers)Shengtao Lin (5 shared papers)
- Journals
- Oncotarget (4 papers)Molecular Carcinogenesis (3 papers)Journal of Clinical Oncology (2 papers)European Journal of Surgical Oncology (2 papers)Medical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Liming Wang
60 papers receiving 680 citations
Peers
Comparison fields: 5 of 70
- Hepatology 273
- Transplantation 12
- Oncology 118
- Cancer Research 59
- Pathology and Forensic Medicine 66
Countries citing papers authored by Liming Wang
This map shows the geographic impact of Liming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Wang more than expected).
Fields of papers citing papers by Liming Wang
This network shows the impact of papers produced by Liming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Wang. The network helps show where Liming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 52 | |
| 2 | 2013 | 52 | |
| 3 | 2017 | 45 | |
| 4 | 2021 | 42 | |
| 5 | CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. | 2017 | 40 |
| 6 | 2017 | 30 | |
| 7 | 2022 | 28 | |
| 8 | 2017 | 26 | |
| 9 | 2019 | 20 | |
| 10 | 2013 | 20 | |
| 11 | 2019 | 19 | |
| 12 | 2020 | 17 | |
| 13 | 2013 | 17 | |
| 14 | 2016 | 16 | |
| 15 | 2014 | 14 | |
| 16 | 2013 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2015 | 13 | |
| 19 | 2023 | 12 | |
| 20 | 2020 | 12 |
About Liming Wang
Liming Wang is a scholar working on Hepatology, Surgery, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 63 papers that have together received 688 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Mechanisms and Therapy (3 papers), Immune Cell Function and Interaction (3 papers), RNA modifications and cancer (3 papers), Poxvirus research and outbreaks (2 papers), Vitamin D Research Studies (2 papers) and Bacillus and Francisella bacterial research (2 papers). The work is most often cited by research in Hepatology (273 citations), Transplantation (12 citations), Oncology (118 citations), Cancer Research (59 citations) and Pathology and Forensic Medicine (66 citations). Liming Wang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jianxiong Wu, Weiqi Rong, Fan Wu, Weihu Wang, Bo Chen, Weibo Yu, Liguo Liu, Shengtao Lin, Quan Xu and Ye‐Xiong Li. Their work appears in journals such as Oncotarget, Molecular Carcinogenesis, Journal of Clinical Oncology, European Journal of Surgical Oncology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.